Idiosyncratic drug hepatotoxicity
The DOI matches its Crossref record; 154 of the 155 references it cites were found in a registry or an index.
Abstract
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the most frequent cause of post-marketing warnings and withdrawals. This review examines the clinical signatures of this problem, signals predictive of its occurrence (particularly of more frequent, reversible, low-grade injury) and the role of monitoring in prevention by examining several recent examples (for example, troglitazone). In addition, the failure of preclinical toxicology to predict idiosyncratic reactions, and what can be done to improve this problem, is discussed. Finally, our current understanding of the pathophysiology of experimental drug hepatotoxicity is examined, focusing on acetaminophen, particularly with respect to the role of the innate immune system and control of cell-death pathways, which might provide targets for exploration and identification of risk factors and mechanisms in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current drug development process suffers from a high failure rate during clinical trials, which is partly due to inadequacy of animal models to accurately predict the toxic side-effects of drugs in humans [1,2].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [2]
In the citing paper
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [1]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO
Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29664-1 · Cited by 1,204
Acetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
ANDRADE, R., LUCENA, M., FERNANDEZ, M., PELAEZ, G., PACHKORIA, K., GARCIARUIZ, E., GARCIAMUNOZ, B., GONZALEZGRANDE, R., PIZARRO, A., & DURAN, J. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.006 · Cited by 856
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Research works printed but not linked: 3
- Nelson, S. D. & Bruschi, S. A. in Drug-Induced Liver Disease (eds Kaplowitz, N. & DeLeve, L.) 287–325 (Marcel Dekker, New York, 2003).
- Chien, J. Y., Thummel, K. E. & Slattery, J. T. Pharmakinetic consequence of induction of CYP2E1 by ligand stabilization. Drug Metab. Dispos. 25, 1165–1175 (1997).
- Liu, Z. -X. & Kaplowitz, N. in Clinics in Liver Disease 6, 467–486 (Elsevier, 2002).
Cited by
Items 301–400 of 999
Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome
Martínez‐Cabriales, S. A., Shear, N. H., & González-Moreno, E. I. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i6.705 · Cited by 56
Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury
Bourdi, M., Korrapati, M. C., Chakraborty, M., Yee, S. B., & Pohl, L. R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.065 · Cited by 55
Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety
Wang, J., Urbán, L., & Bojanic, D. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.5.641 · Cited by 58
HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage
Yuan, J., Guo, L., Ma, J., Zhang, H., Xiao, M., Li, N., Gong, H., & Yan, M. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09893-2 · Cited by 60
The Use of Hepatocytes to Investigate Drug Toxicity
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-688-7_21 · Cited by 51
Toxicogenetics: Population-Based Testing of Drug and Chemical Safety in Mouse Models
Rusyn, I., Gatti, D. M., Wilshire, T., Kleeberger, S. R., & Threadgill, D. W. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.100 · Cited by 58
Greaves, P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-444-53856-7.00009-9 · Cited by 61
Pan, Y., Cao, M., You, D., Qin, G., & Liu, Z. (2019) · BioMed Research International · doi:10.1155/2019/1283824 · Cited by 53
Hepatocyte transplantation and drug-induced perturbations in liver cell compartments
Wu, Y., Joseph, B., Berishvili, E., Kumaran, V., & Gupta, S. K. (2007) · Hepatology · doi:10.1002/hep.21937 · Cited by 53
Mosedale, M., Kim, Y., Brock, W. J., Roth, S. E., Wiltshire, T., Eaddy, J. S., Keele, G. R., Corty, R. W., Xie, Y., Valdar, W. S. J., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw269 · Cited by 58
Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity
Otto, M. H., Hansen, S. H., Dalgaard, L., Dubois, J., & Badolo, L. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-9018-x · Cited by 50
Pachkoria, K., Lucena, M. I., Ruiz‐Cabello, F., Crespo, E., Cabello, M. R., Andrade, R. J., & on behalf of the Spanish Group for the Study of Drug‐Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos (GEHAM) (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707122 · Cited by 49
Kunjiappan, S., Bhattacharjee, C., & Chowdhury, R. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9841-3 · Cited by 50
Leone, A. M., Nie, A. Y., Parker, J. B., Sawant, S. P., Piechta, L.-A., Kelley, M. F., Kao, L. M., Proctor, S. J., Verheyen, G. R., Johnson, M. D., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.01.017 · Cited by 53
Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes
Dang, N. L., Hughes, T. B., Miller, G. P., & Swamidass, S. J. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00336 · Cited by 53
Drug-Induced Liver Injury After COVID-19 Vaccine
Mann, R., Sekhon, S., & Sekhon, S. S. (2021) · Cureus · doi:10.7759/cureus.16491 · Cited by 47
Peck, Y., & Wang, D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.751096 · Cited by 52
Kramer, O. N., & Albrecht, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15854 · Cited by 47
Samra, Y. A., Hamed, M. F., & El‐Sheakh, A. R. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22470 · Cited by 49
Mechanism of Exacerbative Effect of Progesterone on Drug-Induced Liver Injury
Toyoda, Y., Endo, S., Tsuneyama, K., Miyashita, T., Yano, A., Fukami, T., Nakajima, M., & Yokoi, T. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr326 · Cited by 46
Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Roth, A. D., & Lee, M. (2017) · BioMed Research International · doi:10.1155/2017/9176937 · Cited by 54
Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model
Liao, C.-C., Day, Y., Lee, H.-C., Liou, J.-T., Chou, A., & Liu, F.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166856 · Cited by 50
Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072
Paech, F., Messner, S., Spickermann, J., Wind, M., Schmitt-Hoffmann, A.-H., Witschi, A. T., Howell, B. A., Church, R. J., Woodhead, J., Engelhardt, M. F., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1994-x · Cited by 50
A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis
Kang, S., Kimura, M., Shrestha, S., Lewis, P., Lee, S., Cai, Y., Joshi, P., Acharya, P., Liu, J., Yang, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302502 · Cited by 44
The application of engineered liver tissues for novel drug discovery
Lin, C., Ballinger, K. R., & Khetani, S. R. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032241 · Cited by 44
Li, L., Zhang, T., Zhou, L., Zhou, L., Xing, G., Chen, Y., & Xin, Y. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12425 · Cited by 44
Granitzny, A., Knebel, J., Müller, M., Braun, A., Steinberg, P., Dasenbrock, C., & Hansen, T. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.02.001 · Cited by 44
Feng, C., Chen, H., Yuan, X., Sun, M., Chu, K., Liu, H., & Rui, M. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00143 · Cited by 44
Win, S., Min, R. W. M., Chen, C. Q., Zhang, J., Chen, Y., Li, M., Suzuki, A., Abdelmalek, M. F., Wang, Y., Aghajan, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128289 · Cited by 46
Self-citationChen, S., Wu, Q., Li, X., Li, D., Mei, N., Ning, B., Puig, M., Ren, Z., Tolleson, W. H., & Guo, L. (2021) · Journal of Environmental Science and Health, Part C · doi:10.1080/26896583.2021.1880242 · Cited by 44
LC-MS Untargeted Metabolomic Analysis of Drug-Induced Hepatotoxicity in HepG2 Cells
García‐Cañaveras, J. C., Jiménez, N., Gómez‐Lechón, M. J., Castell, J. V., Donato, M. T., & Lahoz, A. (2015) · ELECTROPHORESIS · doi:10.1002/elps.201500095 · Cited by 41
Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs
Lee, C., Wang, J., & Chen, P. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1966 · Cited by 48
Wolf, K., Vora, S., Webster, L. O., Generaux, G. T., Polli, J. W., & Brouwer, K. L. R. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.08.009 · Cited by 45
Mahesh, A., Shaheetha, J., Thangadurai, D., & Rao, D. M. (2009) · Biologia · doi:10.2478/s11756-009-0205-5 · Cited by 44
The reciprocal roles of PARK2 and mitofusins in mitophagy and mitochondrial spheroid formation
Yin, X.-M., & Ding, W.-X. (2013) · Autophagy · doi:10.4161/auto.24871 · Cited by 43
Tacrine-induced liver damage: an analysis of 19 candidate genes
Alfirevic, A., Mills, T., Carr, D. F., Barratt, B. J., Jawaid, A., Sherwood, J. L., Smith, J. C., Tugwood, J. D., Hartkoorn, R. C., Owen, A., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f1f12b · Cited by 43
Ruoß, M., Häussling, V., Schügner, F., Olde Damink, L. H. H., Lee, S. M. L., Ge, L., Ehnert, S., & Nussler, A. K. (2018) · Bioengineering · doi:10.3390/bioengineering5040086 · Cited by 43
Allergic hepatitis induced by drugs
Castell, J. V., & Castell, M. (2006) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/01.all.0000235898.80052.80 · Cited by 43
Gutkowski, K., Chwist, A., & Hartleb, M. (2011) · Hepatitis Monthly · doi:10.5812/kowsar.1735143x.713 · Cited by 43
Recent status of drug‐induced liver injury
Takikawa, H. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00400.x · Cited by 42
Weaver, R. J., Betts, C., Blomme, E. A. G., Gerets, H. H. J., Gjervig Jensen, K., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 42
Drug-induced liver injury: a safety review
García‐Cortés, M., Ortega‐Alonso, A., Lucena, M. I., & Andrade, R. J. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1505861 · Cited by 47
Gastrointestinal and liver side effects of drugs in elderly patients
Τriantafyllou, Κ., Vlachogiannakos, J., & Ladas, S. D. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.02.004 · Cited by 52
Liver Damage and microRNAs: An Update
Cione, E., Abrego-Guandique, D. M., Caroleo, M. C., Luciani, F., Colosimo, M., & Cannataro, R. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb45010006 · Cited by 43
Role of drug-independent stress factors in liver injury associated with diclofenac intake
Ramm, S., & Mally, A. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.002 · Cited by 44
Markers of Electrophilic Stress Caused by Chemically Reactive Metabolites in Human Hepatocytes
Takakusa, H., Masumoto, H., Mitsuru, A., Okazaki, O., & Sudo, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.018002 · Cited by 43
Cho, Y.-E., Kim, S., Lee, B.-H., & Baek, M. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.174 · Cited by 41
In vitro functional models for human liver diseases and drug screening: beyond animal testing
Paradiso, A., Volpi, M., Rinoldi, C., Celikkin, N., Contessi Negrini, N., Bilgen, M., Dallera, G., Pierini, F., Costantini, M., Święszkowski, W., et al. (2023) · Biomaterials Science · doi:10.1039/d1bm01872h · Cited by 40
Spraggs, C. F., Xu, C., & Hunt, C. M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.24 · Cited by 41
Iida, A., Sasaki, E., Yano, A., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063370 · Cited by 41
Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury
Mikus, M., Drobin, K., Gry, M., Bachmann, J., Lindberg, J., Yimer, G., Aklillu, E., Makonnen, E., Aderaye, G., Roach, J., et al. (2017) · Liver International · doi:10.1111/liv.13174 · Cited by 40
Yamazaki, H., Suemizu, H., Mitsui, M., Shimizu, M., & Guengerich, F. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00136 · Cited by 46
Hepatotoxicity: Treatment, causes and applications of medicinal plants as therapeutic agents
Thompson, M., Jaiswal, Y. S., Wang, I., & Williams, L. L. (2017) · The Journal of Phytopharmacology · doi:10.31254/phyto.2017.6308 · Cited by 48
Bavachinin Induces Oxidative Damage in HepaRG Cells through p38/JNK MAPK Pathways
Wang, S., Wang, M., Wang, M., Tian, Y., Sun, X. Y., Sun, G., & Sun, X. (2018) · Toxins · doi:10.3390/toxins10040154 · Cited by 40
What is idiosyncratic hepatotoxicity? What is it not?
Senior, J. R. (2008) · Hepatology · doi:10.1002/hep.22332 · Cited by 40
Geenen, S., Guallar-Hoyas, C., Michopoulos, F., Kenna, J. G., Kolaja, K. L., Westerhoff, H. V., Thomas, P., & Wilson, I. D. (2011) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2011.06.001 · Cited by 39
Local Kinetics and Dynamics of Xenobiotics
Pelkonen, O., Kapitulnik, J., Gundert‐Remy, U., Boobis, A. R., & Stockis, A. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802194931 · Cited by 40
Wewering, F., Jouy, F., Wissenbach, D. K., Gebauer, S., Blüher, M., Gebhardt, R., Pirow, R., von Bergen�, M., Kalkhof, S., Luch, A., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1686-y · Cited by 43
Hunt, C. M. (2010) · Hepatology · doi:10.1002/hep.24022 · Cited by 39
Medower, C., Wen, L., & Johnson, W. W. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700430n · Cited by 39
Practical approaches to resolving reactive metabolite liabilities in early discovery
Dalvie, D., Kalgutkar, A. S. S., & Chen, W. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.984813 · Cited by 41
State-of-the-art genomics approaches in toxicology
Hummelen, P. V., & Sasaki, J. C. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.04.007 · Cited by 38
Vliegenthart, A. D. B., Berends, C., Potter, C. M. J., Kersaudy‐Kerhoas, M., & Dear, J. W. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13282 · Cited by 38
Pannala, V. R., Vinnakota, K. C., Rawls, K. D., Estes, S. K., O’Brien, T. P., Printz, R. L., Papin, J. A., Reifman, J., Shiota, M., Young, J. D., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.04.001 · Cited by 40
Models of Idiosyncratic Drug-Induced Liver Injury
Yokoi, T., & Oda, S. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-015007 · Cited by 38
Estradiol and progesterone modulate halothane-induced liver injury in mice
Toyoda, Y., Miyashita, T., Endo, S., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.03.031 · Cited by 40
The Role of Transporters in Toxicity and Disease
Schuetz, J. D., Swaan, P. W., & Tweedie, D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.057539 · Cited by 37
Quantitative Assessment of Reactive Metabolite Formation using 35S-labeled Glutathione
Takakusa, H., Masumoto, H., Makino, C., Okazaki, O., & Sudo, K. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.100 · Cited by 37
Oda, S., Matsuo, K., Nakajima, A., & Yokoi, T. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.10.029 · Cited by 38
Quantitative Chemical Proteomic Profiling of thein VivoTargets of Reactive Drug Metabolites
Whitby, L. R., Obach, R. S., Simon, G. M., Hayward, M. M., & Cravatt, B. F. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00346 · Cited by 40
Tu, C., He, Q., Li, C., Niu, M., Han, Z., Ge, F., Zhou, Y., Zhang, L., Wang, X., Zhu, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00335 · Cited by 42
Liver spheroids on chips as emerging platforms for drug screening
Huang, D., Zhang, X., Fu, X., Zu, Y., Sun, W., & Zhao, Y. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.10.003 · Cited by 45
Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes
Choi, J. M., Oh, S. J., Lee, J.-Y., Jeon, J. S., Ryu, C. S., Kim, Y., Lee, K., & Kim, S. K. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500504n · Cited by 37
Flynn, T. J., & Ferguson, M. S. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.04.016 · Cited by 37
Fischer, J. J., Dalhoff, C., Schrey, A. K., Graebner, O. Y., Michaelis, S., Andrich, K., Glinski, M., Kroll, F. K., Sefkow, M., Dreger, M., et al. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.035 · Cited by 39
de Lima Toccafondo Vieira, M., & Tagliati, C. A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.884069 · Cited by 36
Yang, F., Liang, Y., Xu, L., Ji, L., Yao, N., Liu, R., Shi, L., & Liang, T. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.017 · Cited by 38
The use of SAMe in chemotherapy-induced liver injury
Vincenzi, B., Russo, A. D., Terenzio, A., Galvano, A., Santini, D., Vorini, F., Incalzi, R. A., Gentilucci, U. V., & Tonini, G. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.019 · Cited by 39
Xiao, R., Lv, T., Tu, X., Li, P., Wang, T., Dong, H., Tu, P., & Ai, X. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27931 · Cited by 38
Flucloxacillin-induced liver injury
Andrews, E., & Daly, A. K. (2008) · Toxicology · doi:10.1016/j.tox.2008.08.009 · Cited by 37
Nakayama, S., Takakusa, H., Watanabe, A., Miyaji, Y., Suzuki, W., Sugiyama, D., Shiosakai, K., Honda, K., Okudaira, N., Izumi, T., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039180 · Cited by 36
Toxicogenomics Strategies for Predicting Drug Toxicity
Martin, R. B., Rose, D. M., Yu, K., & Barros, S. A. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.7.1003 · Cited by 39
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Ellison, C. M., Enoch, S. J., & Cronin, M. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.629186 · Cited by 35
Karimi, K., Keßler, T., Thiele, K., Ramisch, K., Erhardt, A., Huebener, P., Barikbin, R., Arck, P., & Tiegs, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.020 · Cited by 35
Liver inflammation and regeneration in drug-induced liver injury: sex matters!
Sutti, S., & Tacke, F. (2018) · Clinical Science · doi:10.1042/cs20171313 · Cited by 40
Matsuzaka, Y., Hosaka, T., Ogaito, A., Yoshinari, K., & Uesawa, Y. (2020) · Molecules · doi:10.3390/molecules25061317 · Cited by 35
Takai, S., Oda, S., Tsuneyama, K., Fukami, T., Nakajima, M., & Yokoi, T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3141 · Cited by 35
Dear, J. W., & Antoine, D. J. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.880650 · Cited by 34
Kim, M. K., Jeong, W., Jeon, S., & Kang, H.-W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1305023 · Cited by 38
Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue
Fine, B. M., & Vunjak‐Novakovic, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00662 · Cited by 37
Ruan, L., Li, M., Xing, Y.-X., Wei, H., Cheng, C., Chen, J.-F., Xu, H., Zhao, W., & Wang, J. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.10.032 · Cited by 37
Laifenfeld, D., Qiu, L., Swiss, R. L., Park, J., Macoritto, M. P., Will, Y., Younis, H. S., & Lawton, M. P. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft232 · Cited by 35
Idiosyncratic drug‐induced liver injury: A short review
Yamashita, Y., Imai, K., Mima, K., Nakagawa, S., Hashimoto, D., Chikamoto, A., & Baba, H. A. (2017) · Hepatology Communications · doi:10.1002/hep4.1064 · Cited by 37
Radovanovic, M., Dushenkovska, T., Cvorovic, I., Radovanović, N., Ramasamy, V., Milosavljevic, K., Surla, J., Jecmenica, M., Radulovic, M., Alempijevic, T. M., et al. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.911393 · Cited by 39
Rao, S., Hossain, T., & Mahmoudi, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.024 · Cited by 37
Illig, C. R., Manthey, C. L., Wall, M. J., Meegalla, S. K., Chen, J., Wilson, K. J., Ballentine, S. K., DesJarlais, R. L., Schubert, C. J., Crysler, C. S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200900q · Cited by 33
Lee, Y. H., Goh, W. W. B., Ng, C. K., Raida, M., Wong, L., Lin, Q., Boelsterli, U. A., & Chung, M. C. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400219s · Cited by 34
Application of urine proteomics for biomarker discovery in drug-induced liver injury
van Swelm, R. P. L., Kramers, C., Masereeuw, R., & Rüssel, F. G. M. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.931341 · Cited by 34
A novel application of metabolomics in vertebrate development
Hayashi, S., Akiyama, S., Tamaru, Y., Takeda, Y., Fujiwara, T., Inoue, K., Kobayashi, A., Maegawa, S., & Fukusaki, E. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.041 · Cited by 34
Metadata
- Authors
- Kaplowitz, N.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Kaplowitz, Neil
- ORCID
- Kaplowitz, Neil
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-06
- Volume
- 4
- Issue
- 6
- Pages
- 489-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2017783406
- Cited by
- 1,054
- References
- 155
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 35 · 2023: 44 · 2022: 31 · 2021: 49 · 2020: 45 · 2019: 48 · 2018: 54 · 2017: 66 · 2016: 72 · 2015: 55 · 2014: 64 · 2013: 57 · 2012: 52
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- drug-induced liver injury, troglitazone, preclinical toxicology, hepatotoxicity prediction, pharmacovigilance, acetaminophen hepatotoxicity, innate immune system, cell death pathways, drug withdrawal, post-marketing surveillance
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Liver, Liver Diseases, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.